β-hydroxy β-methylbutyrate (HMB) supplement
CREC 2022.233-T
Unknown other active
Quick answer
β-hydroxy β-methylbutyrate (HMB) supplement for Sarcopenia is a Unknown program (other) at Chinese University of Hong Kong with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Chinese University of Hong Kong
- Indication
- Sarcopenia
- Phase
- Unknown
- Modality
- other
- Status
- active